Table 1.
Clinical characteristics of 123 stage I LUAD with or without oncogenic alterations.
| Characteristic | Total (N = 123) | Without Genetic Alterations in Tumor (N = 21) | With Genetic Alterations in Tumor (N = 102) | p-Value | |
|---|---|---|---|---|---|
| Age | ≤60 | 55 (44.7%) | 12 (21.8%) | 43 (78.2%) | |
| >60 | 68 (55.3%) | 9 (13.2%) | 59 (86.6%) | 0.208 | |
| Sex | Male | 78 (63.4%) | 16 (20.5%) | 62 (79.5%) | |
| Female | 45 (36.6%) | 5 (11.1%) | 40 (88.9%) | 0.182 | |
| Smoke | No | 69 (56.1%) | 6 (8.7%) | 63 (91.3%) | |
| Yes | 54 (43.9%) | 15 (27.8%) | 39 (72.2%) | 0.005 | |
| Family history | No | 82 (66.7%) | 11 (13.4%) | 71 (86.6%) | |
| Yes | 41 (33.3%) | 10 (24.4%) | 31 (75.6%) | 0.127 | |
| Tumor Size | ≤3 cm | 107 (87.0%) | 18 (16.8%) | 89 (83.2%) | |
| >3 cm | 16 (13.0%) | 3 (18.8%) | 13 (81.3%) | 0.736 | |
| Surgery type | Lobectomies | 113 (91.9%) | 18 (15.9%) | 95 (84.1%) | |
| Segmentectomies | 10 (8.1%) | 3 (30.0%) | 7 (70.0%) | 0.372 | |
p was calculated by Chi-square test or Fisher’s exact test.